2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of thePsychosis Market from 2025 to 2034?

The increasing cases of mental health conditions are expected to propel the growth of the psychosis market. Mental health conditions, including psychosis, are becoming more prevalent, particularly due to rising stress levels, lifestyle changes, and social isolation. These conditions are often treated with antipsychotic medications and therapy options. According to the National Alliance on Mental Illness, psychosis and mood disorders account for nearly 600,000 hospitalizations annually among individuals aged 18-44 in the U.S. The rising number of mental health conditions, along with growing awareness and treatment options, is driving the growth of the psychosis market as more people seek medical intervention.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

#What Long-Term Growth Rate is Expected for thePsychosis Market Between 2025 and 2034?

The psychosis market has grown steadily, increasing from $9.88 billion in 2024 to $10.49 billion in 2025 at a CAGR of 6.1%. Growth drivers include rising cases of mental health conditions, increasing demand for mental health therapeutics, wider adoption of typical and atypical antipsychotics, greater use of cognitive behavioral therapy (CBT), and the impact of stress-inducing global and economic factors.

The psychosis market is expected to experience robust growth, reaching $13.13 billion by 2029 at a CAGR of 5.8%. Factors fueling this growth include the increasing prevalence of stress-related conditions, rising mental health concerns due to lifestyle changes, government initiatives, greater adoption of mindfulness-based therapies, and increased investments in mental health research. Notable trends include the introduction of innovative drug therapies, advancements in diagnostic tools, the development of injectable treatments, the use of biomarkers, and a growing demand for personalized medications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21266

How Are Market Trends and Innovations Revolutionizing thePsychosis Industry in Recent Times?

Leading companies in the psychosis market are focusing on the development of advanced virtual reality (VR) psychological therapy to enhance treatment outcomes through interactive and personalized mental health interventions. VR psychological therapy immerses individuals in controlled, computer-generated environments to reduce distress, enhance cognitive function, and improve social skills through guided interventions, offering a safe and effective approach to symptom management. For example, in April 2022, OxfordVR, a US-based digital therapeutics company, introduced gameChangeVR to guide patients through cognitive behavioral therapy (CBT) in immersive virtual scenarios. The automated VR therapy, delivered across six weekly sessions, demonstrated significant benefits, especially for those facing severe psychological challenges, improving their paranoia and overall quality of life. This technology has the potential to greatly expand access to effective mental health care, addressing the shortage of clinicians and providing a scalable solution for treating millions of patients with severe mental illness.

Which Key Market Players Are Shaping the Future and Growth of thePsychosis Market?

Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy’s Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

What Are the Core Segments of the Psychosis Market, and How Do They Contribute to Growth?

The psychosis market covered in this report is segmented –

1) By Product: Tablet, Capsule, Injection

2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types

3) By Distribution Channel: Online, Offline

4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users

Subsegments:

1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets

2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules

3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp

What Regions Are Dominating the Psychosis Market Growth?

North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Psychosis Market 2025, By The Business Research Company:

Insulin Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Non-injectable Insulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: